| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |